Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 16.63% is 10% above its 5-year average of 15.09%, near the high end of its 5-year range (4.59%–19.08%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.98% above its 12-month average of 15.70%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 16.63%.
RETURN ON EQUITY (ROE)
16.63%
RETURN ON EQUITY (ROE) AVG TTM
15.70%
RETURN ON EQUITY (ROE) AVG 3Y
15.74%
RETURN ON EQUITY (ROE) AVG 5Y
15.09%
RETURN ON EQUITY (ROE) AVG 10Y
9.18%
RETURN ON EQUITY (ROE) AVG 15Y
3.77%
RETURN ON EQUITY (ROE) AVG 20Y
-4.10%
CURRENT VS TTM AVG
+5.98%
CURRENT VS 3Y AVG
+5.68%
CURRENT VS 5Y AVG
+10.23%
CURRENT VS 10Y AVG
+81.28%
CURRENT VS 15Y AVG
+340.84%
CURRENT VS 20Y AVG
+506.16%
SECTOR MEDIAN · HEALTHCARE
-40.30%
median of 608 covered companies
CURRENT VS SECTOR MEDIAN
+141.27%
vs the sector median at left
Option Care Health, Inc.
Market Cap
$4.65B
Return on Equity (ROE)
16.63%
TTM Avg
15.70%
3Y Avg
15.74%
5Y Avg
15.09%
Market Cap
$4.62B
Return on Equity (ROE)
6.24%
TTM Avg
-11.62%
3Y Avg
-98.18%
5Y Avg
-98.18%
Market Cap
$4.70B
Return on Equity (ROE)
3.43%
TTM Avg
-1.67%
3Y Avg
-7.64%
5Y Avg
-9.04%
Market Cap
$4.75B
Return on Equity (ROE)
-38.51%
TTM Avg
-50.16%
3Y Avg
-65.11%
5Y Avg
-61.13%
Market Cap
$4.45B
Return on Equity (ROE)
-44.68%
TTM Avg
-52.94%
3Y Avg
-55.51%
5Y Avg
-46.01%
Market Cap
$4.44B
Return on Equity (ROE)
N/A
TTM Avg
-107.43%
3Y Avg
-58.28%
5Y Avg
-52.10%
Market Cap
$4.86B
Return on Equity (ROE)
-2.55%
TTM Avg
-28.50%
3Y Avg
-30.36%
5Y Avg
-30.19%
Market Cap
$4.88B
Return on Equity (ROE)
-11.92%
TTM Avg
-22.12%
3Y Avg
-20.62%
5Y Avg
-23.54%
Market Cap
$4.38B
Return on Equity (ROE)
-44.02%
TTM Avg
-30.64%
3Y Avg
-28.05%
5Y Avg
-12.80%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Option Care Health, Inc. (OPCH) | $4.65B | 16.63% | 15.70% | 15.74% | 15.09% |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 6.24% | -11.62% | -98.18% | -98.18% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 3.43% | -1.67% | -7.64% | -9.04% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.75B | -38.51% | -50.16% | -65.11% | -61.13% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | -44.68% | -52.94% | -55.51% | -46.01% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | N/A | -107.43% | -58.28% | -52.10% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | -2.55% | -28.50% | -30.36% | -30.19% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.88B | -11.92% | -22.12% | -20.62% | -23.54% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.38B | -44.02% | -30.64% | -28.05% | -12.80% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.92B | N/A | -23.20% | -51.91% | -56.25% |
ROE
16.6%
ROA
6.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 16.63% |
| 2026-03-31 | 15.26% |
| 2025-12-31 | 15.65% |
| 2025-09-30 | 15.40% |
| 2025-06-30 | 15.53% |
| 2025-03-31 | 15.83% |
| 2024-12-31 | 15.08% |
| 2024-09-30 | 14.64% |
| 2024-06-30 | 14.97% |
| 2024-03-31 | 19.08% |
| 2023-12-31 | 18.79% |
| 2023-09-30 | 17.88% |
| 2023-06-30 | 16.26% |
| 2023-03-31 | 11.81% |
| 2022-12-31 | 10.86% |
| 2022-09-30 | 13.35% |
| 2022-06-30 | 13.63% |
| 2022-03-31 | 14.16% |
| 2021-12-31 | 11.90% |
| 2021-09-30 | 7.50% |
| 2021-06-30 | 4.59% |
| 2021-03-31 | 0.88% |
| 2020-12-31 | -0.80% |
| 2020-09-30 | -4.20% |
| 2020-06-30 | -9.93% |
| 2020-03-31 | -10.82% |
| 2019-12-31 | -8.60% |
| 2019-09-30 | -8.41% |
| 2015-03-31 | -69.45% |
| 2014-12-31 | -68.02% |
| 2014-09-30 | -36.77% |
| 2014-06-30 | -31.04% |
| 2014-03-31 | -26.11% |
| 2013-12-31 | -19.64% |
| 2013-09-30 | -11.86% |
| 2013-06-30 | -5.33% |
| 2013-03-31 | 20.62% |
| 2012-12-31 | 22.05% |
| 2012-09-30 | 22.66% |
| 2012-06-30 | 25.88% |
| 2012-03-31 | 1.04% |
| 2011-12-31 | 3.66% |
| 2011-09-30 | -31.93% |
| 2011-06-30 | -31.69% |
| 2011-03-31 | -28.92% |
| 2010-12-31 | -34.55% |
| 2010-09-30 | 14.53% |
| 2010-06-30 | 16.20% |
| 2010-03-31 | 17.01% |
| 2009-12-31 | 34.72% |
| 2009-09-30 | -56.06% |
| 2009-06-30 | -64.51% |
| 2009-03-31 | -70.58% |
| 2008-12-31 | -77.49% |
| 2008-09-30 | 2.95% |
| 2008-06-30 | 3.14% |
| 2008-03-31 | 2.51% |
| 2007-12-31 | 2.00% |
| 2007-09-30 | -16.79% |
| 2007-06-30 | -20.25% |
| 2007-03-31 | -24.32% |
| 2006-12-31 | -23.66% |
| 2006-09-30 | -17.37% |
| 2006-06-30 | -15.11% |
| 2006-03-31 | -13.60% |
| 2005-12-31 | -12.18% |
| 2005-09-30 | -0.02% |
| 2005-06-30 | 0.48% |
| 2005-03-31 | 2.97% |
| 2004-12-31 | 6.08% |
| 2004-09-30 | 5.95% |
| 2004-06-30 | 5.64% |
| 2004-03-31 | 7.20% |
| 2003-12-31 | 8.52% |
| 2003-09-30 | 12.75% |
| 2003-06-30 | 16.33% |
